MALAT1 and gastric cancer: The results of protein stability assay showed that the low levels of δ‐catenin in gastric cancer cells treated with si‐MALAT1 M2‐EX could be rescued by MG‐132 treatment (Figure 4E), indicating that MALAT1 may maintain δ‐catenin protein stability in gastric cancer cells.